[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100627814":3},{"organization":4,"outcomesModule":7,"designInfo":47,"detailedDescription":19,"studyPopulation":19,"armGroups":53,"interventions":58,"overallOfficials":19,"centralContacts":19,"locations":63,"responsibleParty":83,"collaborators":19,"id":85,"slug":19,"hasResults":86,"nctId":87,"briefTitle":88,"officialTitle":89,"acronym":90,"eligibilityCriteria":91,"healthyVolunteers":86,"sex":92,"minAge":93,"maxAge":19,"enrollmentInfo":94,"targetDuration":19,"studyType":97,"phases":98,"briefSummary":99,"conditions":100,"keywords":19,"overallStatus":66,"whyStopped":19,"lastUpdateSubmitDate":102,"lastUpdatePostDateStruct":103,"startDateStruct":106,"completionDateStruct":108,"leadSponsor":110,"locationsCount":111},{"fullName":5,"class":6},"Université Catholique de Louvain","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":19},[9],{"measure":10,"description":11,"timeFrame":12},"Chronic pain patient preferences of pain medications regarding pain relief relative to the side effects using numeric rating scales (adaptation of the outcome prioritization tool).","Using numeric rating scales from 0 to 10 (adaptation of the outcome prioritization tool) to assess patient perceived importance of analgesic effect relative to not having the following side effects: fatigue, drowsiness (sleepiness), dizziness, difficulty concentrating, nausea, constipation (difficulty passing stools), dry mouth, unintentional weight gain, addiction (medication craving). Higher scores mean the specific outcome is a higher priority for the participant.","Single measure at a time selected by the participant within the study period (up to 15 months).",[14,17,20,23,26,29,32,35,38,41,44],{"measure":15,"description":16,"timeFrame":12},"Analgesic side effect burden measured by numeric rating scales (NRS)","Using numeric rating scales, from 0 to 10, to assess current burden of the following analgesic side effects: fatigue, drowsiness (sleepiness), dizziness, difficulty concentrating, nausea, constipation (difficulty passing stools), dry mouth, unintentional weight gain, addiction (medication craving). Higher scores mean being more affected by the side effects.",{"measure":18,"description":19,"timeFrame":12},"Patient pain levels in the last 24 hours and pain body location and its impact on functioning measured by the Brief Pain Inventory short form (BPI-SF).",null,{"measure":21,"description":22,"timeFrame":12},"Overall pain levels in the past 7 days measured by a numeric rating scale.","Numeric rating scale from 0 to 10, with higher scores meaning higher pain levels.",{"measure":24,"description":25,"timeFrame":12},"Overall sleep quality in the past 7 days measured by a numeric rating scale.","Numeric rating scale from 0 to 10, with higher scores meaning better sleep.",{"measure":27,"description":28,"timeFrame":12},"Satisfaction of pain treatment will be assessed by select items from the PTSS","Patient treatment satisfaction will be assessed using 6 selected items from the Pain Treatment Satisfaction Scale (PTSS). The 6 items using 5-point Likert scales assess satisfaction of the time that it takes their pain medication to work, level or amount of pain relief, duration of pain relief, overall satisfaction, and to what extend the level of pain relief meet their expectations.",{"measure":30,"description":31,"timeFrame":12},"Evaluating Patient characteristics","Patient characteristics including demographics and which pain type\u002Fdiagnosis and medications and dose are used including alternative\u002Fsupplementary treatments.",{"measure":33,"description":34,"timeFrame":12},"MacArthur Scale of Subjective Social Status assessing subjective social status","Single-item measure, on a scale from 1 to 10, that assesses a person's perceived rank relative to others with a higher score meaning a higher rank.",{"measure":36,"description":37,"timeFrame":12},"Single Item Global Quality of Life Scale (SIG-QoL)","Assessing global quality of life through a Numerical Rating Scale on a scale from 0 to 100 that includes 11 descriptive markers where a higher scores means a better QOL.",{"measure":39,"description":40,"timeFrame":12},"Patient Health Questionnaire-4 (PHQ-4) is used to measure anxiety and depression","The PHQ-4 uses a 4-point Likert scale (Not at all, Several days, More than half the days, Nearly every day).",{"measure":42,"description":43,"timeFrame":12},"Current Opioid Misuse Measure - 9 items (COMM-9) is used to identify current aberrant opioid-related behavior in chronic pain patients on long-term opioid therapy","The COMM-9 uses a 5-point Likert scale (Never, Seldom, Sometimes, Often, Very often).",{"measure":45,"description":46,"timeFrame":12},"PROMIS Item Bank v2.0 - Cognitive Function- Short Form 4a assesses patient-perceived cognitive deficits.","The PROMIS Item Bank v2.0 - Cognitive Function- Short Form 4a uses a 5-point Likert scale (Never, Rarely (Once), Sometimes (Two or three times), Often (About once a day), Very often (Several times a day)).",{"allocation":48,"interventionModel":49,"interventionModelDescription":19,"primaryPurpose":50,"observationalModel":19,"timePerspective":19,"maskingInfo":51},"NA","SINGLE_GROUP","BASIC_SCIENCE",{"masking":52,"maskingDescription":19,"whoMasked":19},"NONE",[54],{"label":55,"type":6,"description":19,"interventionNames":56},"Chronic pain patients",[57],"Other: Patient questionnaire",[59],{"type":6,"name":60,"description":61,"armGroupLabels":62,"otherNames":19},"Patient questionnaire","Online patient questionnaire that assesses multiple aspects such as current analgesic use, side effect burden, treatment satisfaction and patient preferences.",[55],[64],{"facility":65,"status":66,"city":67,"state":19,"zip":68,"country":69,"countryCode":70,"cosmosGeoPoint":71,"geoPoint":76,"contacts":77},"UCLouvain\u002FIONS","RECRUITING","Brussels","1200","Belgium","BE",{"type":72,"coordinates":73},"Point",[74,75],4.34878,50.85045,{"lat":75,"lon":74},[78],{"name":79,"role":80,"phone":81,"phoneExt":19,"email":82},"André Mouraux","CONTACT","0032 2 436 19 15","andre.mouraux@uclouvain.be",{"type":84,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100627814",false,"NCT07453524","Assessing Chronic Pain Patient Preferences","Assessing Chronic Pain Patient Preferences Regarding the Analgesic Effect Relative to the Side Effects of Analgesic Drugs","patientPREF","Inclusion Criteria:\n\n* Aged over 18 years.\n* Being treated with pain medication.\n* (Chronic-)Pain for at least 3 months.\n* Capacity to understand and provide an informed consent form.\n\nExclusion Criteria:\n\n* Insufficient French or English language skills.\n* Epilepsy treated by an anti-epileptic.\n* Alzheimer's disease.\n* Parkinson's disease","ALL","18 Years",{"count":95,"type":96},200,"ESTIMATED","INTERVENTIONAL",[48],"The goal of this study is to ask chronic pain patients their preferences regarding which side effects of pain medications are least acceptable in relation to their pain relief benefits. This information may help in the selection of improved treatment options in the future.",[101],"Chronic Pain","2026-06-11",{"date":104,"type":105},"2026-06-15","ACTUAL",{"date":107,"type":105},"2026-03-15",{"date":109,"type":96},"2027-12-31",{"name":5,"class":6},1]